EcoDrugPlus

Ensembl ID : ENSBSLG00000017494
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000015807
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000023888
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSBSLG00000012027
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSBSLG00000024032
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSBSLG00000012844
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSBSLG00000017771
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000024696
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000012262
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000025098
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000012119
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSBSLG00000007068
Gene Symbol: -
Cross references: -
435 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).